Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Israel Biotech Fund

Status
ACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
  • Israel
Investment stages
  • Seed
  • Series A
Industries
    About
    Israel Biotech Fund is dedicated to generating high-value returns by strategically identifying and fostering the growth of promising therapeutic assets within Israeli biotech companies. Focusing exclusively on firms developing drugs that are at or near clinical stages, the fund not only provides financial investment but also offers hands-on support and expertise. By leveraging its extensive industry knowledge and networks, Israel Biotech Fund aims to accelerate the development of innovative therapies, ultimately contributing to advancements in healthcare and improving patient outcomes.
    Min check size
    $500K
    Max check size
    $10M
    Fund size
    NPS

    Investment Thesis

    Israel Biotech Fund targets investments in companies that are working on cuttingedge biotechnology and healthcare innovations. The firm seeks startups with strong scientific and technological foundations, promising clinical or preclinical results, and significant potential for impact in the biotech industry. Israel Biotech Fund provides capital, strategic support, and access to a network of industry experts to help its portfolio companies achieve success.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Israel Biotech Fund Contacts Information

    Primary contact

    Secondary contact

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp